ROLE OF GENETIC ALTERATIONS IN BREAST CANCER PROGRESSION.

Breast cancer is a multifactorial disease and represents the tumor formation through non-controlled cellular proliferation in the breast tissue. To understand the concept of breast cancer, one has to study the types, risk factors, diagnosis, treatment and latest research about the disease[1].While breast cancer remains a premier health concern, the advances made in research methods and tools, early detection and treatments have dramatically improved survival rates and quality of life for many patients [2].The incidence rates for breast cancer have been on the increase due to increased awareness, better diagnostic facilities and changes in lifestyle[3].The Wnt signaling pathway normally plays a very fundamental role in cell growth, differentiation and embryonic development. Understanding this pathway is important for the development of targeted therapies and advanced understanding in the advancement of regenerative medicine[4].HCCRI is an abbreviation of Human Cervical cancer Related 1, a gene implicated in the development of cancer especially in cervical cancer. It encodes for a protein involved in regulating all proliferation and apoptosis. Overexpression of HCCRI has been implicated in tumor progressions and prognosis in various cancers. Research indicates that HCCRI could be utilized as a biomarker for diagnosis in cancer and prognosis while the targeting of HCCRI can offer new therapeutic strategies in managing cancer[5].The TIMP2 gene encodes a tissue inhibitor of metalloproteinases 2-a protein that plays a critical role in regulating extracellular matrix remodeling through the inhibition of matrix metalloproteinases. This inhibition controls the degradation and remodeling of tissue leading to various physiological processes such as wound healing and embryogenesis. TIMP2 is involved in maintaining tissue integrity and has been implicated in various pathological conditions including cancer metastasis and cardiovascular diseases. It operates by binding to MMPs, thus preventing their activity and subsequent breakdown of extracellular characterized by excessive tissue remodelling or insufficient tissue repair[6].

Authors

Publication Details

Published
2025-01-01
DOI
https://doi.org/10.53555/eijbps.v11i1.61
Primary Topic
Nutrition, Genetics, and Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ROLE OF GENETIC ALTERATIONS IN BREAST CANCER PROGRESSION.

Tandralee Bhuyan
Nutrition, Genetics, and Disease
article

ROLE OF GENETIC ALTERATIONS IN BREAST CANCER PROGRESSION.

Tandralee Bhuyan
article en

Abstract

Breast cancer is a multifactorial disease and represents the tumor formation through non-controlled cellular proliferation in the breast tissue. To understand the concept of breast cancer, one has to study the types, risk factors, diagnosis, treatment and latest research about the disease[1].While breast cancer remains a premier health concern, the advances made in research methods and tools, early detection and treatments have dramatically improved survival rates and quality of life for many patients [2].The incidence rates for breast cancer have been on the increase due to increased awareness, better diagnostic facilities and changes in lifestyle[3].The Wnt signaling pathway normally plays a very fundamental role in cell growth, differentiation and embryonic development. Understanding this pathway is important for the development of targeted therapies and advanced understanding in the advancement of regenerative medicine[4].HCCRI is an abbreviation of Human Cervical cancer Related 1, a gene implicated in the development of cancer especially in cervical cancer. It encodes for a protein involved in regulating all proliferation and apoptosis. Overexpression of HCCRI has been implicated in tumor progressions and prognosis in various cancers. Research indicates that HCCRI could be utilized as a biomarker for diagnosis in cancer and prognosis while the targeting of HCCRI can offer new therapeutic strategies in managing cancer[5].The TIMP2 gene encodes a tissue inhibitor of metalloproteinases 2-a protein that plays a critical role in regulating extracellular matrix remodeling through the inhibition of matrix metalloproteinases. This inhibition controls the degradation and remodeling of tissue leading to various physiological processes such as wound healing and embryogenesis. TIMP2 is involved in maintaining tissue integrity and has been implicated in various pathological conditions including cancer metastasis and cardiovascular diseases. It operates by binding to MMPs, thus preventing their activity and subsequent breakdown of extracellular characterized by excessive tissue remodelling or insufficient tissue repair[6].

Openalex Percentile: Top 88%
Nutrition, Genetics, and Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

ROLE OF GENETIC ALTERATIONS IN BREAST CANCER PROGRESSION. — Tandralee Bhuyan · (2025) | TGRS Research Map | TGRS